Concentrix Corp Prices $600M Senior Notes

By Chris Stiles • Monday, February 16 15:31 • Permanent Link

Concentrix Corporation (NASDAQ: CNXC) has announced the pricing of a public offering of $600 million aggregate principal amount of 6.500% senior notes due 2029. The company intends to use the net proceeds, along with other available funds, to redeem or repay a portion of its 6.650% senior notes due August 2, 2026, of which $800 million aggregate principal amount is outstanding as of the announcement date, and to pay related fees and expenses. The offering is expected to close on February 24, 2026.

The joint book-running managers for the offering are BofA Securities, Inc., J.P. Morgan Securities LLC, BNP Paribas Securities Corp., Citigroup Global Markets Inc., HSBC Securities (USA) Inc., PNC Capital Markets LLC, TD Securities (USA) LLC, Truist Securities, Inc., U.S. Bancorp Investments, Inc., and Wells Fargo Securities, LLC. Additionally, Fifth Third Securities, Inc., Goldman Sachs & Co. LLC, MUFG Securities Americas Inc., and Standard Chartered Bank are acting as co-managers for the offering.

Concentrix Corporation is a Fortune 500 company and a global technology and services leader that powers over 2,000 clients in solving their toughest business challenges across 70+ markets. The company designs, builds, and runs fully integrated, end-to-end solutions, and is committed to transforming the way companies connect, interact, and grow.

This press release provides an insight into the company's financial strategy and actions to manage its outstanding debts. Following these announcements, the company's shares moved 2.3%, and are now trading at a price of $43.15. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.